Literature DB >> 20713099

Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.

Mi-Ran Park1, Changju Chun, Sung-Won Ahn, Min-Hyo Ki, Chong-Su Cho, Soo-Chang Song.   

Abstract

A combined system of polyelectrolyte complex (PEC) and injectable, biodegradable and thermosensitive poly(organophosphazene) hydrogel has been suggested as an injectable depot for a controlled and sustained delivery of human growth hormone (hGH) to improve patient compliance. PEC was prepared by mixing polycations with hGH to suppress diffusion of hGH from the hydrogel through an enlargement of the hydrodynamic size of hGH. Among the polycations, poly-L-arginine (PLA) formed a large complex with hGH and its size increased as the amount of PLA increased. When PLA and/or zinc were added to hGH, the time-dependent stability of hGH increased more than that of native-hGH. The polymer solution containing PECs formed a gel at 37°C. PLA decreased the initial release rate of hGH in proportion to the amount of PLA in vitro and in vivo. Zinc increased the released amount of hGH from the PEC-loaded hydrogel in vitro and in vivo. In a pharmacokinetic study in rats, a single administration of PEC-loaded hydrogel resulted in the sustained release of hGH for 5days. These results suggest that injectable, biodegradable, and thermosensitive PEC-loaded poly(organophosphazene) hydrogel has great potential to be used as an effective delivery system for a sustained release of hGH with improved patient compliance.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713099     DOI: 10.1016/j.jconrel.2010.07.126

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  16 in total

1.  Biomedical Applications of Biodegradable Polymers.

Authors:  Bret D Ulery; Lakshmi S Nair; Cato T Laurencin
Journal:  J Polym Sci B Polym Phys       Date:  2011-06-15

2.  Weak Bond-Based Injectable and Stimuli Responsive Hydrogels for Biomedical Applications.

Authors:  Xiaochu Ding; Yadong Wang
Journal:  J Mater Chem B       Date:  2016-12-16       Impact factor: 6.331

3.  Extended and sequential delivery of protein from injectable thermoresponsive hydrogels.

Authors:  Devin M Nelson; Zuwei Ma; Cory E Leeson; William R Wagner
Journal:  J Biomed Mater Res A       Date:  2012-01-11       Impact factor: 4.396

4.  Recent developments in protein and peptide parenteral delivery approaches.

Authors:  Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-03

Review 5.  Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2018-02-07       Impact factor: 3.633

6.  Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.

Authors:  Kevin C J Yuen; Rakesh Amin
Journal:  Patient Prefer Adherence       Date:  2011-03-10       Impact factor: 2.711

Review 7.  A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury.

Authors:  Poornima Ramburrun; Pradeep Kumar; Yahya E Choonara; Divya Bijukumar; Lisa C du Toit; Viness Pillay
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

Review 8.  Hydrogel: Preparation, characterization, and applications: A review.

Authors:  Enas M Ahmed
Journal:  J Adv Res       Date:  2013-07-18       Impact factor: 10.479

Review 9.  Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes.

Authors:  Yunpeng Cai; Mingxin Xu; Minglu Yuan; Zhenguo Liu; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2014-07-25

10.  Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement.

Authors:  Mary L Reed; George R Merriam; Atil Y Kargi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.